Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02101736
Title Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +)
Acronym NF105-CABO
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Children's National Medical Center Washington District of Columbia 20010 United States Details
Lurie Children's Hospital of Chicago Chicago Illinois 60611 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana Unversity Indianapolis Indiana 46202 United States Details
National Cancer Institute (NCI) Bethesda Maryland 20892 United States Details
Children' Hospital Boston and Massachusetts General Hospital Boston Massachusetts 02115 United States Details
Washington University - St. Louis Saint Louis Missouri 63110 United States Details
New York University Medical Center New York New York 10016 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19096 United States Details
University of Utah Salt Lake City Utah 84132 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field